πŸ‡ΊπŸ‡Έ FDA
Patent

US 12139487

Compounds and uses thereof

granted A61KA61K45/06A61P

Quick answer

US patent 12139487 (Compounds and uses thereof) held by FOGHORN THERAPEUTICS INC. expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
FOGHORN THERAPEUTICS INC.
Grant date
Tue Nov 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
102
CPC classes
A61K, A61K45/06, A61P, A61P35/00